Citadel Advisors’s Strategic Trust Kelly CRISPR & Gene Editing Technology ETF XDNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,449	Closed	-$137K	–	6730
2023 Q1	$137K	Sell	15,449 -7,307	-32%	-$65K	﹤0.01%	4789
2022 Q4	$226K	Sell	22,756 -1,455	-6%	-$14.5K	﹤0.01%	4587
2022 Q3	$284K	Buy	+24,211	New	+$284K	﹤0.01%	4593